# Sunphenon in Progressive Forms of Multiple Sclerosis

> **NCT00799890** · PHASE2,PHASE3 · COMPLETED · sponsor: **Friedemann Paul** · enrollment: 61 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Sunphenon EGCG
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00799890
- **Lead sponsor:** Friedemann Paul
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2021-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00799890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00799890, "Sunphenon in Progressive Forms of Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00799890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*